Universität Witten/Herdecke

Fetal Assessment in Pregnancy (Indication and Methodology for Fetal Monitoring in a low-risk Population). Guideline of the DGGG, DEGUM, OEGGG and SGGG (S3-Level, AWMF Registry No. 015/089, February 2023) (2023) Schiermeier S, Von Kaisenberg CS, Kehl S, Reister F, Mosimann B, Reif P, Harlfinger W, et al. Journal article Corrigendum: Position statement and updated international guideline for safe and effective whole-body electromyostimulation training-the need for common sense in WB-EMS application (Frontiers in Physiology, (2023), 14, (1174103), 10.3389/fphys.2023.1174103) (2023) Kemmler W, Fröhlich M, Ludwig O, Eifler C, von Stengel S, Willert S, Teschler M, et al. Journal article, Erratum Rapid recovery of poststroke cardiac autonomic dysfunction: Causes to be considered (2023) Wang R, Moeller S, Akhundova A, Marthol H, Kollmar R, Köhrmann M, Hilz MJ Journal article Prospective Newborn Screening for SCID in Germany: A First Analysis by the Pediatric Immunology Working Group (API) (2023) Speckmann C, Nennstiel U, Hoenig M, Albert MH, Ghosh S, Schuetz C, Brockow I, et al. Journal article Epidemiology and Characteristics of Gastric Carcinoma in Childhood—An Analysis of Data from Population-Based and Clinical Cancer Registries (2023) Abele M, Grabner L, Blessing T, Block A, Agaimy A, Kratz C, Simon T, et al. Journal article Prognostic markers for the clinical course in the blood of patients with SARS-CoV-2 infection (2022) Fischer JC, Balz V, Jazmati D, Bölke E, Freise NF, Keitel V, Feldt T, et al. Journal article Prioritization preferences for COVID-19 vaccination are consistent across five countries (2022) Munzert S, Ramirez-Ruiz S, Çalı B, Stoetzer LF, Gohdes A, Lowe W Journal article Autologous hematopoietic stem cell transplantation improves long-term survival-data from a national registry (2022) Blank N, Schmalzing M, Moinzadeh P, Oberste M, Siegert E, Mueller-Ladner U, Riemekasten G, et al. Journal article S2k Guideline for the diagnosis and treatment of mucous membrane pemphigoid (2022) Hofmann SC, Gunther C, Bockle BC, Didona D, Ehrchen J, Gaskins M, Geerling G, et al. Journal article GeparPiPPa- A randomized, open-label, phase II trial comparing neoadjuvant trastuzumab, pertuzumab and endocrine therapy +/- the PI3K inhibitor inavolisib in patients (pts) with HER2+/HR+, PIK3CA mutant early breast cancer (BC) (2022) Loibl S, Reinisch M, Denkert C, Schneeweiss A, Seiler S, Fasching P, Hanusch C, et al. Conference contribution